Diagnostic and Interventional Cardiology

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry #Amyloidosis

News | Cardiac Diagnostics

Amyloidosis Patient Registry Hits 300 Participants and Now Open to Entire Community

March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the ...

March 05, 2020

TeraRecon will accelerate innovation in its advanced visualization and AI platforms for image-related decision support to clinical specialists

News | Artificial Intelligence

SymphonyAI Group Acquires TeraRecon

March 4, 2020 — SymphonyAI Group, an operating group of leading business-to-business AI companies, today announced the ...

March 04, 2020

Fears and travel restrictions due to the coronavirus has caused two European medical conferences to postpone their meetings so far in 2020. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Feature | Dave Fornell, Editor

Coronavirus Fears Cancel European Cardiology and Radiology Conferences

March 3, 2020 — Two sizable European medical conferences in cardiology and radiology were canceled today as fears ...

March 03, 2020

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Coronavirus (COVID-19) and the FDA clearance of the Micra AV, the world’s smallest pacemaker with atrioventricular (AV) synchrony, topped the news analytics in February 2020 on DAIC magazine. COVID-19 virus image courtesy of CDC.

Feature | Dave Fornell, Editor

March 2, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

March 02, 2020

AI vendor Infravision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis tp improve the overall efficiency of the radiology department. It is being delayed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID-19 #COVID19 #Coronavirus #2019-nCoV

Feature | Coronavirus (COVID-19)

Emerging Technologies Proving Value in Chinese Coronavirus Fight

February 28, 2020 — New healthcare technologies are being implemented in the fight against the novel coronavirus (COVID ...

February 28, 2020

Videos | Structural Heart

VIDEO: Overview of the Structural Heart Program at Tufts Medical Center

Charles D. Resor, M.D., MSc, assistant director, cardiac catheterization lab, Tufts Medical Center and assistant ...

February 27, 2020

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Aria CV Pulmonary Hypertension System_Aria CV PH System

News | Hypertension

Aria CV Pulmonary Hypertension Acquires $31 Million for Feasibility Study

February 27, 2020 — Aria CV Inc. completed a $31 million Series B round of financing to fund its first clinical study in ...

February 27, 2020

The LivaNova Heater-Cooler System 3T helps open heart surgery patients, but can pose an infection risk if not properly cared for.

News | Cardiovascular Surgery

How to Reduce the Risk of Cardiac Surgery Infection When Using LivaNova Heater-Cooler System

February 27, 2020 — The U.S. Food and Drug Administration (FDA) sent a safety communication this week to healthcare to ...

February 27, 2020

Videos | Tufts Medical Center

VIDEO: Tufts Medical Center Spearheads Innovation With its Preclinical Cath Lab

Lara Reyelt, veterinary technician and preclinical surgeon at the Interventional Research Laboratories (SIRL) at Tufts ...

February 26, 2020

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

An illustration of the novel coronavirus (COVID-19) from the CDC. #coronavirus #COVID19 #COVID-2019 #2019nCoV

Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

CDC Hopes to Buy Time Before Likely Coronavirus Spread in U.S.

The Centers for Disease Control and Prevention (CDC) said it is working to contain the spread of the novel coronavirus ...

February 25, 2020

A 3-D reconstruction of a cardiac CT scan showing an implanted Medtronic CoreValve TAVR device. Imagine courtesy of TeraRecon. #TAVR #TAVI

Feature | Heart Valve Technology | Dave Fornell, Editor

TAVR Expected to See Rapid Growth in Next 5 years

In August 2019, the U.S. Food and Drug Administration (FDA) expanded the indication for the use of transcatheter aortic ...

February 24, 2020

NC Trek RX Coronary Dilatation Catheter is part of an FDA Class I recall because it may not defalte.

News | Balloon Catheter

Abbott Recalls Two Coronary Balloon Catheters That May Not Deflate

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

February 24, 2020

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Biotronik announced three-year data from the BIOFLOW-V Trial, which was presented yesterday at the 2020 Cardiovascular Research Technologies (CRT) Congress. The three-year follow-up data demonstrates consistently lower clinical event rates and improvement in patient outcomes, reinforcing the differentiation of the Orsiro coronary drug-eluting stent (DES), which is the first DES to outperform Xience.

News | Stents

Biotronik's Orsiro Stent Continues Excellent Results After Three Years

February 24, 2020 — Biotronik announced three-year data from the BIOFLOW-V Trial, which was presented yesterday at the ...

February 24, 2020

The U.S. Food and Drug Administration (FDA) approved Esperion's bempedoic acid (Nexletor) tablet, an oral, once-daily, non-statin low-density lipoprotein cholesterol (LDL-C) lowering medicine. The drug is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDL-C.

Feature | Pharmaceuticals

FDA Clears Bempedoic Acid Non-statin LDL-cholesterol Lowering Drug

February 24, 2020 — The U.S. Food and Drug Administration (FDA) approved Esperion's bempedoic acid (Nexletor) tablet, an ...

February 24, 2020

Some of the new devices technologies to treat heart failure that are either in clinical trials or were recently cleared by the U.S. FDA. #heartfailure

Feature | Heart Failure | Dave Fornell, Editor

New Heart Failure Devices and Drugs to Treat Heart Failure

There are several new tools being added to the clinical armamentarium in the fight against heart failure (HF). These ...

February 21, 2020